Jacobs Levy Equity Management, Inc Deciphera Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $650,970 - $832,168	47,936 Added 11.3%	471,977 $7.42 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $2.86 Million - $4.68 Million	-283,062 Reduced 40.03%	424,041 $6.84 Million
Q3 2023 Nov 16, 2023	SELL	$12.46 - $15.48 $1.85 Million - $2.29 Million	-148,172 Reduced 17.32%	707,103 $8.99 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $303,607 - $364,877	-22,862 Reduced 2.6%	855,275 $12 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $4.88 Million - $7.56 Million	-341,943 Reduced 28.03%	878,137 $13.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $1.36 Million - $1.74 Million	-91,476 Reduced 6.97%	1,220,080 $20 Million
Q3 2022 Nov 15, 2022	BUY	$12.38 - $20.23 $1.39 Million - $2.28 Million	112,547 Added 9.39%	1,311,556 $24.3 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $8.64 Million - $13.3 Million	948,069 Added 377.81%	1,199,009 $15.8 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $7,398 - $11,965	-1,077 Reduced 0.43%	250,940 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $1.78 Million - $8.59 Million	231,382 Added 1121.31%	252,017 $2.46 Million
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $1.48 Million - $2.08 Million	-55,937 Reduced 73.05%	20,635 $701,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $1.16 Million - $1.7 Million	-35,411 Reduced 31.62%	76,572 $2.8 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $2.95 Million - $4.14 Million	72,947 Added 186.87%	111,983 $5.02 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $2.02 Million - $2.58 Million	39,036 New	39,036 $2.23 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account